Quality indicators for osteoarthritis pain management in the primary care setting

Author:

Rizk Elsie,Tajchman Sharla,Fink Ezekiel,Aryal Dipendra K.,Iso Tomona,Flores Eleazar,Brown Anthony E.,Chokshi Sagar P.,Desai Shetal-Nicholas,Dewan Ashvin K.,Kazzaz Sarah A.,Guevara Myriam,Nagaraj Sudha,Robben Christopher P.,Vittone Veronica,Swan Joshua T.

Abstract

Abstract Background Development of valid and feasible quality indicators (QIs) is needed to track quality initiatives for osteoarthritis pain management in primary care settings. Methods Literature search identified published guidelines that were reviewed for QI extraction. A panel of 14 experts was assembled, including primary care physicians, rheumatologists, orthopedic surgeons, pain specialists, and outcomes research pharmacists. A screening survey excluded QIs that cannot be reliably extracted from the electronic health record or that are irrelevant for osteoarthritis in primary care settings. A validity screening survey used a 9-point Likert scale to rate the validity of each QI based on predefined criteria. During expert panel discussions, stakeholders revised QI wording, added new QIs, and voted to include or exclude each QI. A priority survey used a 9-point Likert scale to prioritize the included QIs. Results Literature search identified 520 references published from January 2015 to March 2021 and 4 additional guidelines from professional/governmental websites. The study included 41 guidelines. Extraction of 741 recommendations yielded 115 candidate QIs. Feasibility screening excluded 28 QIs. Validity screening and expert panel discussion excluded 73 QIs and added 1 QI. The final set of 15 prioritized QIs focused on pain management safety, education, weight-management, psychological wellbeing, optimizing first-line medications, referral, and imaging. Conclusion This multi-disciplinary expert panel established consensus on QIs for osteoarthritis pain management in primary care settings by combining scientific evidence with expert opinion. The resulting list of 15 prioritized, valid, and feasible QIs can be used to track quality initiatives for osteoarthritis pain management.

Funder

Pfizer

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine,Rheumatology

Reference70 articles.

1. Centers for Disease Control and Prevention. Osteoarthritis (OA). 2020.

2. Centers for Disease Control and Prevention. A national public health agenda for osteoarthritis: 2020 update. 2020.

3. US Bone and Joint Initiative. The burden of musculoskeletal diseases in the United States. https://www.boneandjointburden.org/fourth-edition/iiib10/osteoarthritis. Accessed 27 June 2023.

4. Centers for Disease Control and Prevention. Joint Pain and Arthritis. 2020.

5. Alamanda VK, Wally MK, Seymour RB, Springer BD, Hsu JR, Prescription Reporting With Immediate Medication Utilization Mapping G. Prevalence of opioid and benzodiazepine prescriptions for osteoarthritis. Arthritis Care Res. 2020;72(8):1081–6.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3